AGP Executive Report
Last update: 3 hours agoPharma Tariffs, Liechtenstein Included: The US Commerce Department says it will apply a 0% ad valorem tariff to certain “specialty” drugs and ingredients imported from India and 19 other jurisdictions, including Liechtenstein, even as a 100% tariff on covered patented pharma imports is set to start Sept. 29. The carve-out targets treatments for rare diseases, infertility, cell and gene therapies, antibody-drug conjugates, and animal pharmaceuticals, with components also covered. Trade & Industry Link: A separate report notes the exemption is tied to qualifying trade and security frameworks, meaning eligibility isn’t automatic. EFTA Deal Moves Through Brazil: Brazil has formally incorporated the Mercosur-EFTA free trade agreement; preferential tariffs for Switzerland and Liechtenstein depend on their internal procedures. Local Market Watch: Geely has entered Switzerland with three new energy models, with Emil Frey also acting as importer for Liechtenstein.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.